医学
可视模拟标度
恶心
安慰剂
术后恶心呕吐
呕吐
麻醉
乳房外科
外科
体质指数
随机对照试验
乳腺癌
内科学
替代医学
病理
癌症
作者
Marcos Sforza,Manu Sidhu,Renée Okhiria,Terrell Okhiria,Reyan Saghir,Norman Saghir,Rodwan Husein,Manoj Poojary,Amelia Seifalian
出处
期刊:
日期:2023-09-29
卷期号:43 (4): 225-230
被引量:3
标识
DOI:10.1097/psn.0000000000000534
摘要
We conducted a double-blind, randomized, placebo-controlled, single-center study involving 30 women undergoing breast augmentation surgery with silicone breast implants. All patients had an A cup breast size and a similar body mass index. We placed the same type of implant in a subpectoral dual plane in each patient. We randomly allocated the study participants to receive either three drops of ginger oil (110 mg Zingiber officinale) or three drops of a placebo control oil placed on their laryngeal mask before insertion. We used a postoperative nausea and vomiting (PONV) and a visual analog scale (VAS) scores as outcome measures and compared the scale results with the dose of morphine used by the patient. The results of the multivariate analysis of variance showed that the ginger oil had a significant effect on PONV/VAS scores, V = 0.87, F(3, 16) = 34.78, p < .001. The results of the univariate analysis of variance showed that using the ginger oil provided significant treatment effects on PONV, F(1, 18) = 73.05, p < .001. These results are also reflected in the descriptive statistics. The mean PONV score for the experimental group and the control group was 1.70 ± 0.48 and 4.20 ± 0.79, respectively. The mean VAS score for the experimental group and the control group was 5.0 ± 1.63 and 5.9 ± 2.33, respectively. The results of our study showed that ginger oil has an important role in preventing PONV and reducing the use of postoperative opioids in women who have undergone breast augmentation surgery.
科研通智能强力驱动
Strongly Powered by AbleSci AI